Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Apellis Pharmaceuticals, Inc. - Common Stock (NQ:APLS)

17.30 -0.51 (-2.86%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Apellis Pharmaceuticals, Inc. - Common Stock

< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
20 Stocks Moving in Friday's Pre-Market Session
Gainers IVERIC bio, Inc. (NASDAQ: ISEE) rose 29.6% to $11.26 in pre-market trading. Iveric Bio recently reported inducement grants under Nasdaq Listing Rule 5635(c)(4). T2... 
Via Benzinga
Apellis Unveils Mixed Results For Eye Disorder Drug, But Still Hopes To Pass FDA Finish Line
Apellis Pharmaceuticals Inc's (NASDAQ: APLS) pegcetacoplan posted mixed results in two Phase 3 trials in 1,258 geographic atrophy (GA). Despite the mixed... 
Via Benzinga
Exposures Product Safety
Where Apellis Pharmaceuticals Stands With Analysts
Analysts have provided the following ratings for Apellis Pharmaceuticals (NASDAQ: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 19, 2021
Upgrades According to DA Davidson, the prior rating for PaySign Inc (NASDAQ: 
Via Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
Via Benzinga
Exposures Product Safety
Analyst Ratings For Apellis Pharmaceuticals
Within the last quarter, Apellis Pharmaceuticals (NASDAQ:APLS... 
Via Benzinga
Recap: Apellis Pharmaceuticals Q2 Earnings
Shares of Apellis Pharmaceuticals (NASDAQ:APLS) fell in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share decreased 73.25% year... 
Via Benzinga
Unusual Options Activity Insight: Apellis Pharmaceuticals
Shares of Apellis Pharmaceuticals (NASDAQ:APLS) saw some unusual options activity on Thursday. Following the unusual option alert, the stock price moved down to $65.4. Sentiment... 
Via Benzinga
10 Biggest Price Target Changes For Thursday
DA Davidson lowered the price target for WD-40 Company (NASDAQ: 
Via Benzinga
10 Biggest Price Target Changes For Friday
Credit Suisse raised the price target for Capital One Financial Corporation (NYSE: 
Via Benzinga
The Daily Biotech Pulse: Iterum's Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 1) Alexion Pharmaceuticals, Inc... 
Via Benzinga
The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) Ambrx Biopharma Inc. (NYSE... 
Via Benzinga
Exposures Product Safety
Apellis, Beam Ink $75M Deal To Test Base Gene Editing Against Complement Disorders
Beam Therapeutics Inc (NASDAQ: BEAM) joins forces with Apellis Pharmaceuticals Inc (NASDAQ: APLS) to create new gene-editing treatments for complement-driven... 
Via Benzinga
The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 15) Apellis Pharmaceuticals,... 
Via Benzinga
Exposures COVID-19 Product Safety
The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 24) AngioDynamics, Inc. (NASDAQ... 
Via Benzinga
Exposures COVID-19
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers RAPT Therapeutics (NASDAQ:RAPT) s... 
Via Benzinga
The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 10) Alexion Pharmaceuticals,... 
Via Benzinga
The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS... 
Via Benzinga
The Daily Biotech Pulse: Lyra Gains On Positive Regulatory Outcome, FDA Nod For Pfizer's Prevnar Vaccine, Merck Inks COVID-19 Treatment Supply Deal With US
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 8) Agios Pharmaceuticals, Inc... 
Via Benzinga
Exposures COVID-19 Product Safety
The Daily Biotech Pulse: FDA Nod For Novartis, iRhythm CEO Quits Abruptly, Moderna Inks Vaccine Supply Agreements
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 1) Anika Therapeutics, Inc. (... 
Via Benzinga
Exposures Product Safety
Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates
The FDA review machinery worked overtime in May, completing reviews of several drug applications. Except for stray rejections or delays, the agency churned out mostly positive... 
Via Benzinga
Exposures Product Safety
Apellis-Sobi Partnered Pegcetacoplan Shows Clinically Meaningful Improvements in Rare Blood Disorder Study
Apellis Pharmaceuticals Inc (NASDAQ: APLS) and Swedish Orphan Biovitrum AB (SOBI) have reported positive top-line results from the Phase 3 PRINCE... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers AnPac Bio-Medical Science (NASDAQ:ANPC) shares increased by 27.99% to $5.99 during Tuesday's pre-market session. The market value of their outstanding shares... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 21, 2021
Upgrades According to JP Morgan, the prior rating for ResMed Inc (NYSE:RMD) was changed from Neutral to Overweight. For the third quarter, ResMed had an EPS of $1.30,... 
Via Benzinga
Mid-Afternoon Market Update: Nasdaq Drops Over 100 Points; Apellis Pharmaceuticals Shares Spike Higher
Toward the end of trading Monday, the Dow traded down 0.21% to 34,310.36 while the NASDAQ fell 0.86% to 13,314.36. The S&P also fell, dropping 0.42% to 4,156.26. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
58 Biggest Movers From Yesterday
Gainers Peabody Energy Corporation (NYSE: BTU) shares gained 32.3% to settle at $8.60 on Monday. Nuvve Holding Corp. (NASDAQ: NVVE) shares jumped 30.9% to close at $10.80 on... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Aerpio Pharmaceuticals (NASDAQ:ARPO) shares increased by 55.85% to $1.81 during Monday's regular session. The current volume of 136.6 million shares is 10519.... 
Via Benzinga
Mid-Day Market Update: Gold Rises 1.5%; FreightCar America Shares Slide Following Q1 Results
Midway through trading Monday, the Dow traded down 0.54% to 34,194.82 while the NASDAQ fell 0.92% to 13,306.55. The S&P also fell, dropping 0.60% to 4,148.77. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
40 Stocks Moving In Monday's Mid-Day Session
Gainers Nuvve Holding Corp. (NASDAQ: NVVE) shares surged 22.2% to $10.08 after the company announced an agreement with Evolve Transition Infrastructure and Stonepeak to purse a $... 
Via Benzinga
Mid-Morning Market Update: Markets Down; AT&T, Discovery To Merge Media Assets
Following the market opening Monday, the Dow traded down 0.24% to 34,300.61 while the NASDAQ fell 0.48% to 13,366.03. The S&P also fell, dropping 0.23% to 4,164.05. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.